Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4028) 4028
Book Review (986) 986
Publication (301) 301
Newsletter (70) 70
Book / eBook (65) 65
Book Chapter (34) 34
Newspaper Article (20) 20
Conference Proceeding (8) 8
Dissertation (5) 5
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3734) 3734
humans (3524) 3524
female (1656) 1656
male (1644) 1644
middle aged (1263) 1263
pancreatic cancer (1188) 1188
cancer (1151) 1151
animals (1145) 1145
pancreatic neoplasms - pathology (1117) 1117
oncology (1091) 1091
aged (1077) 1077
surgery (898) 898
pancreatic neoplasms - blood supply (860) 860
pancreatic neoplasms - surgery (837) 837
adult (830) 830
mice (686) 686
tumors (627) 627
pancreatic neoplasms - diagnostic imaging (574) 574
pancreas (551) 551
angiogenesis (521) 521
medicine & public health (521) 521
gastroenterology & hepatology (512) 512
cell line, tumor (480) 480
metastasis (465) 465
abridged index medicus (464) 464
pancreas - blood supply (434) 434
pancreatic neoplasms - drug therapy (432) 432
treatment outcome (417) 417
pancreatic-cancer (414) 414
carcinoma (400) 400
pancreatic neoplasms - metabolism (393) 393
care and treatment (380) 380
pancreaticoduodenectomy (374) 374
research (371) 371
adenocarcinoma (365) 365
pancreatic neoplasms - diagnosis (357) 357
chemotherapy (340) 340
expression (333) 333
radiology, nuclear medicine & medical imaging (331) 331
aged, 80 and over (327) 327
retrospective studies (319) 319
mice, nude (308) 308
health aspects (304) 304
angiography (297) 297
tomography, x-ray computed (295) 295
prognosis (292) 292
endothelial growth-factor (283) 283
analysis (277) 277
diagnosis (274) 274
gastroenterology (273) 273
pancreatectomy - methods (273) 273
pancreatectomy (266) 266
pancreatic neoplasms - therapy (261) 261
immunohistochemistry (255) 255
apoptosis (239) 239
survival (233) 233
neoplasm invasiveness (230) 230
cell biology (228) 228
breast-cancer (221) 221
resection (218) 218
therapy (216) 216
pancreatic neoplasms - genetics (212) 212
medicine (209) 209
adenocarcinoma - pathology (207) 207
xenograft model antitumor assays (200) 200
article (196) 196
diagnosis, differential (194) 194
gemcitabine (194) 194
pathology (190) 190
neovascularization, pathologic - pathology (189) 189
neoplasm staging (188) 188
growth (184) 184
adenocarcinoma - blood supply (180) 180
pancreatic neoplasms - mortality (179) 179
neovascularization, pathologic - metabolism (178) 178
antineoplastic agents - therapeutic use (176) 176
cell proliferation (176) 176
signal transduction (176) 176
vascular endothelial growth factor (175) 175
deoxycytidine - analogs & derivatives (174) 174
neoplasm metastasis (172) 172
development and progression (171) 171
pharmacology & pharmacy (169) 169
proteins (168) 168
liver neoplasms - secondary (167) 167
in-vivo (164) 164
adenocarcinoma - surgery (163) 163
ductal adenocarcinoma (163) 163
biochemistry & molecular biology (162) 162
cells (162) 162
risk factors (162) 162
neovascularization, pathologic - drug therapy (161) 161
cancer therapies (157) 157
liver (157) 157
neoplasms - pathology (157) 157
pancreaticoduodenectomy - methods (156) 156
gene expression (155) 155
pancreas - pathology (154) 154
abdominal surgery (153) 153
carcinoma, pancreatic ductal - pathology (153) 153
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3903) 3903
Japanese (84) 84
German (79) 79
French (45) 45
Russian (33) 33
Chinese (23) 23
Spanish (11) 11
Italian (10) 10
Polish (8) 8
Ukrainian (4) 4
Czech (3) 3
Dutch (3) 3
Portuguese (3) 3
Croatian (1) 1
Korean (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
by Chauhan, Vikash P and Martin, John D and Liu, Hao and Lacorre, Delphine A and Jain, Saloni R and Kozin, Sergey V and Stylianopoulos, Triantafyllos and Mousa, Ahmed S and Han, Xiaoxing and Adstamongkonkul, Pichet and Popović, Zoran and Huang, Peigen and Bawendi, Moungi G and Boucher, Yves and Jain, Rakesh K
Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, pp. 2516 - 2516
Cancer and stromal cells actively exert physical forces (solid stress) to compress tumour blood vessels, thus reducing vascular perfusion. Tumour interstitial... 
INTERSTITIAL FLUID PRESSURE | BREAST-CANCER | GROWTH-FACTOR-BETA | PANCREATIC STELLATE CELLS | TGF-BETA | AORTIC-ANEURYSM | SOLID STRESS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | GENE-EXPRESSION | II TYPE-2 RECEPTOR | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling
by Allen, Elizabeth and Miéville, Pascal and Warren, Carmen M and Saghafinia, Sadegh and Li, Leanne and Peng, Mei-Wen and Hanahan, Douglas
Cell Reports, ISSN 2211-1247, 05/2016, Volume 15, Issue 6, pp. 1144 - 1160
Therapeutic targeting of tumor angiogenesis with VEGF inhibitors results in demonstrable, but transitory efficacy in certain human tumors and mouse models of... 
Pancreatic Neoplasms - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Pancreatic Neoplasms - blood supply | Glutamine - metabolism | Stomach Neoplasms - metabolism | Glycolysis - drug effects | Stomach Neoplasms - blood supply | Pancreatic Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Indoles - pharmacology | Membrane Transport Proteins - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Imidazoles - therapeutic use | Pyrroles - therapeutic use | Neuroendocrine Tumors - metabolism | Intestinal Neoplasms - metabolism | Lactic Acid - metabolism | Angiogenesis Inhibitors - pharmacology | Imidazoles - pharmacology | Stomach Neoplasms - drug therapy | Sirolimus - pharmacology | Indazoles - pharmacology | Up-Regulation - drug effects | Pyrroles - pharmacology | Animals | Signal Transduction - drug effects | Models, Biological | Cell Line, Tumor | Glucose - metabolism | Neuroendocrine Tumors - drug therapy | Indoles - therapeutic use | Mice | Intestinal Neoplasms - drug therapy | Indazoles - therapeutic use | Neuroendocrine Tumors - blood supply | Drug Resistance, Neoplasm - drug effects | Intestinal Neoplasms - blood supply | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
by Kenneth P. Olive and Michael A. Jacobetz and Christian J. Davidson and Aarthi Gopinathan and Dominick McIntyre and Davina Honess and Basetti Madhu and Mae A. Goldgraben and Meredith E. Caldwell and David Allard and Kristopher K. Frese and Gina DeNicola and Christine Feig and Chelsea Combs and Stephen P. Winter and Heather Ireland-Zecchini and Stefanie Reichelt and William J. Howat and Alex Chang and Mousumi Dhara and Lifu Wang and Felix Rückert and Robert Grützmann and Christian Pilarsky and Kamel Izeradjene and Sunil R. Hingorani and Pearl Huang and Susan E. Davies and William Plunkett and Merrill Egorin and Ralph H. Hruban and Nigel Whitebread and Karen McGovern and Julian Adams and Christine Iacobuzio-Donahue and John Griffiths and David A. Tuveson
Science, ISSN 0036-8075, 6/2009, Volume 324, Issue 5933, pp. 1457 - 1461
Pancreatic ductal adenocarcinoma (PDA) is among the most lethal human cancers in part because it is insensitive to many chemotherapeutic drugs. Studying a... 
Patent ductus arteriosus | Half lives | Perfusion | Antineoplastics | Ultrasonography | Blood vessels | Reports | Tissue transplantation | Pancreatic neoplasms | Tumors | Apoptosis | SURVIVAL | TRIAL | DIAGNOSIS | METASTASIS | THERAPY | DUCTAL ADENOCARCINOMA | SONIC HEDGEHOG | MULTIDISCIPLINARY SCIENCES | GROWTH | TUMORS | GEMCITABINE | Veratrum Alkaloids - administration & dosage | Neoplasm Transplantation | Pancreatic Neoplasms - metabolism | Receptors, G-Protein-Coupled - metabolism | Apoptosis - drug effects | Stromal Cells - pathology | Veratrum Alkaloids - pharmacokinetics | Humans | Pancreatic Neoplasms - blood supply | Carcinoma, Pancreatic Ductal - metabolism | Neovascularization, Pathologic | Hedgehog Proteins - metabolism | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Antineoplastic Agents - metabolism | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Deoxycytidine - metabolism | Kruppel-Like Transcription Factors - metabolism | Smoothened Receptor | Stromal Cells - drug effects | Disease Models, Animal | Veratrum Alkaloids - therapeutic use | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols | Hedgehog Proteins - antagonists & inhibitors | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Signal Transduction - drug effects | Receptors, G-Protein-Coupled - antagonists & inhibitors | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Zinc Finger Protein GLI1 | Carcinoma, Pancreatic Ductal - blood supply | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Pancreatic cancer | Physiological aspects | Cellular signal transduction | Health aspects | Cancer | Proteins | Signal transduction | Cellular biology | Rodents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
by Jacobetz, Michael A and Chan, Derek S and Neesse, Albrecht and Bapiro, Tashinga E and Cook, Natalie and Frese, Kristopher K and Feig, Christine and Nakagawa, Tomoaki and Caldwell, Meredith E and Zecchini, Heather I and Lolkema, Martijn P and Jiang, Ping and Kultti, Anne and Thompson, Curtis B and Maneval, Daniel C and Jodrell, Duncan I and Frost, Gregory I and Shepard, H M and Skepper, Jeremy N and Tuveson, David A
Gut, ISSN 0017-5749, 01/2013, Volume 62, Issue 1, pp. 112 - 120
Objective Pancreatic ductal adenocarcinoma (PDA) is characterised by stromal desmoplasia and vascular dysfunction, which critically impair drug delivery. This... 
INTERSTITIAL FLUID PRESSURE | CELLS | THERAPY | SOLID TUMORS | MICROENVIRONMENT | PERMEABILITY | DUCTAL ADENOCARCINOMA | GASTROENTEROLOGY & HEPATOLOGY | GEMCITABINE | CHEMOTHERAPY | ENDOTHELIAL GROWTH-FACTOR | Immunohistochemistry | Cell Adhesion Molecules - administration & dosage | Tissue Array Analysis | Pancreatic Neoplasms - blood supply | Antineoplastic Agents - administration & dosage | Hyaluronic Acid - physiology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Drug Delivery Systems | Pancreatic Neoplasms - drug therapy | Hyaluronoglucosaminidase - administration & dosage | Carcinoma, Pancreatic Ductal - mortality | Cell Adhesion Molecules - pharmacology | Pancreatic Neoplasms - mortality | Doxorubicin - administration & dosage | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Mice, Transgenic | Treatment Outcome | Biomarkers, Tumor - physiology | Recombinant Proteins - pharmacology | Recombinant Proteins - administration & dosage | Hyaluronoglucosaminidase - pharmacology | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Pancreatic Ductal - physiopathology | Mice | Carcinoma, Pancreatic Ductal - blood supply | Pancreatic Neoplasms - physiopathology | Drug Resistance, Neoplasm - physiology | Deoxycytidine - analogs & derivatives | Drug Resistance, Neoplasm - drug effects | Care and treatment | Blood-vessels | Pancreatic cancer | Patient outcomes | Physiological aspects | Models | Research | Hyaluronic acid | Tumors | Studies | Angiogenesis | Medical research | Medical prognosis | Cytotoxicity | Extracellular matrix | Permeability | Kinases | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus | stem cells | cell death | cancer vaccines | hyaluronan | epithelial cell growth | cancer immunobiology | drug delivery | matrix | epithelial cell adhesion | cancer genetics | carcinogenesis | pancreatic fibrosis | pharmacology | pharmacokinetics | tumour microenvironment | cancer | fibrosis | pancreatic disease | Original | 1506 | pancreatic tumours | extracellular matrix | oxidative stress
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
by Klug, Felix and Prakash, Hridayesh and Huber, Peter E and Seibel, Tobias and Bender, Noemi and Halama, Niels and Pfirschke, Christina and Voss, Ralf Holger and Timke, Carmen and Umansky, Ludmila and Klapproth, Kay and Schäkel, Knut and Garbi, Natalio and Jäger, Dirk and Weitz, Jürgen and Schmitz-Winnenthal, Hubertus and Hämmerling, Günter J and Beckhove, Philipp
Cancer Cell, ISSN 1535-6108, 11/2013, Volume 24, Issue 5, pp. 589 - 602
Inefficient T cell migration is a major limitation of cancer immunotherapy. Targeted activation of the tumor microenvironment may overcome this barrier. We... 
DESTRUCTION | MICROENVIRONMENT | ANGIOGENESIS | ONCOLOGY | ENDOTHELIUM | INFLAMMATION | PANCREATIC-CANCER | BONE-MARROW | TUMOR-ASSOCIATED MACROPHAGES | TUMORIGENESIS | INFILTRATION | CELL BIOLOGY | Neoplasm Transplantation | Tumor Escape | CD8-Positive T-Lymphocytes - transplantation | Humans | Pancreatic Neoplasms - blood supply | Vaccination | CD4-Positive T-Lymphocytes - immunology | Insulinoma - blood supply | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Inflammation Mediators - metabolism | Female | Macrophages - radiation effects | Radiotherapy, Adjuvant | Insulinoma - immunology | Cell Differentiation - radiation effects | Macrophages - physiology | Radiotherapy Dosage | Immunotherapy, Adoptive | Cells, Cultured | Mice, Transgenic | Mice, SCID | Insulinoma - therapy | Mice, Inbred C3H | Phenotype | Animals | CD4-Positive T-Lymphocytes - transplantation | Melanoma - immunology | Pancreatic Neoplasms - immunology | Mice, Inbred NOD | Mice | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Nitric Oxide Synthase Type II - metabolism | Pancreatic Neoplasms - therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
by Maione, Federica and Capano, Stefania and Regano, Donatella and Zentilin, Lorena and Giacca, Mauro and Casanovas, Oriol and Bussolino, Federico and Serini, Guido and Giraudo, Enrico
Journal of Clinical Investigation, ISSN 0021-9738, 05/2012, Volume 122, Issue 5, pp. 1832 - 1848
Cancer development, progression, and metastasis are highly dependent on angiogenesis. The use of antiangiogenic drugs has been proposed as a novel strategy to... 
MEDICINE, RESEARCH & EXPERIMENTAL | VASCULAR NORMALIZATION | INDUCIBLE FACTOR-1-ALPHA | SQUAMOUS CARCINOGENESIS | PANCREATIC NEUROENDOCRINE TUMORS | MOUSE MODEL | ANTI-ANGIOGENIC THERAPY | GROWTH-FACTOR | K14-HPV16 TRANSGENIC MICE | NF-KAPPA-B | MALIGNANT PROGRESSION | Proto-Oncogene Proteins c-met - metabolism | Genetic Therapy | Pancreatic Neoplasms - metabolism | Uterine Cervical Neoplasms - blood supply | Pancreatic Neoplasms - blood supply | Drug Resistance, Neoplasm | NF-kappa B - metabolism | Uterine Cervical Neoplasms - pathology | Recombinant Proteins - biosynthesis | Semaphorin-3A - biosynthesis | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Pericytes - pathology | Epithelial-Mesenchymal Transition | Angiogenesis Inhibitors - therapeutic use | Female | Indoles - pharmacology | Liver Neoplasms - secondary | Pyrroles - therapeutic use | Uterine Cervical Neoplasms - therapy | Semaphorin-3A - genetics | Neuroendocrine Tumors - pathology | Cell Hypoxia - drug effects | Neoplasm Invasiveness | Neuroendocrine Tumors - metabolism | Pancreatic Neoplasms - pathology | Angiogenesis Inhibitors - pharmacology | Mice, Transgenic | Combined Modality Therapy | Lymphatic Metastasis | Recombinant Proteins - genetics | Tumor Burden | Pyrroles - pharmacology | Animals | Uterine Cervical Neoplasms - virology | Indoles - therapeutic use | Mice | Neuroendocrine Tumors - therapy | Neovascularization, Physiologic | Neuroendocrine Tumors - blood supply | Pancreatic Neoplasms - therapy | Research | Angiogenesis inhibitors | Semaphorins | Cancer cells | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy
by Siddiqui-Jain, Adam and Drygin, Denis and Streiner, Nicole and Chua, Peter and Pierre, Fabrice and O'Brien, Sean E and Bliesath, Josh and Omori, Mayuko and Huser, Nanni and Ho, Caroline and Proffitt, Chris and Schwaebe, Michael K and Ryckman, David M and Rice, William G and Anderes, Kenna
Cancer Research, ISSN 0008-5472, 12/2010, Volume 70, Issue 24, pp. 10288 - 10298
Malignant transformation and maintenance of the malignant phenotype depends on oncogenic and non-oncogenic proteins that are essential to mediate oncogene... 
BREAST-CANCER | HUMAN PROSTATE-CANCER | CASEIN KINASE-2 | APOPTOSIS | AKT/PKB | ONCOLOGY | PHOSPHORYLATION | STABILITY | NON-ONCOGENE ADDICTION | CELL-CYCLE PROGRESSION | EXPRESSION | Humans | Pancreatic Neoplasms - blood supply | Biological Availability | Neovascularization, Pathologic - pathology | Pancreatic Neoplasms - drug therapy | Inflammatory Breast Neoplasms - drug therapy | Female | Inflammatory Breast Neoplasms - blood supply | Inflammatory Breast Neoplasms - enzymology | Protein Kinase Inhibitors - pharmacokinetics | Administration, Oral | Casein Kinase II - antagonists & inhibitors | Pancreatic Neoplasms - enzymology | Random Allocation | Xenograft Model Antitumor Assays | Animals | Naphthyridines - pharmacokinetics | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Neovascularization, Pathologic - metabolism | Protein Kinase Inhibitors - pharmacology | HeLa Cells | Naphthyridines - pharmacology | Endothelial Cells - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
by Provenzano, Paolo P and Cuevas, Carlos and Chang, Amy E and Goel, Vikas K and Von Hoff, Daniel D and Hingorani, Sunil R
Cancer Cell, ISSN 1535-6108, 03/2012, Volume 21, Issue 3, pp. 418 - 429
Pancreatic ductal adenocarcinomas (PDAs) are characterized by a robust fibroinflammatory response. We show here that this desmoplastic reaction generates... 
INTERSTITIAL FLUID PRESSURE | SOLID TUMORS | ONCOLOGY | COMPARING STANDARD PANCREATICODUODENECTOMY | HUMAN OSTEOSARCOMA XENOGRAFTS | RANDOMIZED-TRIAL | HEAD ADENOCARCINOMA | TUMOR VASCULATURE | EXTENDED LYMPHADENECTOMY | CANCER | BLOOD-PRESSURE | CELL BIOLOGY | Adenocarcinoma - pathology | Cell Adhesion Molecules - administration & dosage | Stromal Cells - pathology | Pancreatic Neoplasms - blood supply | Deoxycytidine - pharmacology | Hyaluronic Acid - physiology | Polyethylene Glycols - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Stromal Cells - drug effects | Hyaluronoglucosaminidase - administration & dosage | Drug Evaluation, Preclinical | Hyaluronoglucosaminidase - therapeutic use | Tumor Microenvironment - drug effects | Animals, Genetically Modified | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Microvessels - drug effects | Adenocarcinoma - drug therapy | Carcinoma, Pancreatic Ductal - pathology | Extracellular Fluid - drug effects | Polyethylene Glycols - administration & dosage | Adenocarcinoma - blood supply | Hyaluronoglucosaminidase - pharmacology | Carcinoma, Pancreatic Ductal - drug therapy | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hyaluronic Acid - metabolism | Mice | Carcinoma, Pancreatic Ductal - blood supply | Cell Adhesion Molecules - therapeutic use | Deoxycytidine - analogs & derivatives | Enzymes | Medical colleges | Care and treatment | Glycosaminoglycans | Oncology, Experimental | Research | Chemotherapy | Universities and colleges | Drug therapy | Hyaluronic acid | Public health | Tumors | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Angiogenesis in Synchronous and Metachronous Colorectal Liver Metastases The Liver as a Permissive Soil
by van der Wal, Gesiena E and Gouw, Annette S. H and Kamps, Jan A. A. M and Moorlag, Henk E and Bulthuis, Marian L. C and Molema, Grietje and de Jong, Koert P
Annals of Surgery, ISSN 0003-4932, 01/2012, Volume 255, Issue 1, pp. 86 - 94
Objective: Resection of a primary colorectal carcinoma (CRC) can be accompanied by rapid outgrowth of liver metastases, suggesting a role for angiogenesis. The... 
SURGERY | CELLS | CANCER-PATIENTS | BILIARY TREE | TRANSENDOTHELIAL MIGRATION | PREMETASTATIC NICHE | E-SELECTIN | TUMOR DORMANCY | HUMAN HEPATOCELLULAR-CARCINOMA | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Neoplasms, Multiple Primary - surgery | Colorectal Neoplasms - surgery | Liver - pathology | Cell Proliferation | Platelet Endothelial Cell Adhesion Molecule-1 - genetics | Prognosis | Humans | Middle Aged | Apoptosis - genetics | Male | Neoplasms, Second Primary - surgery | Vascular Endothelial Growth Factor A - genetics | Neovascularization, Pathologic - pathology | Vascular Endothelial Growth Factor Receptor-2 - genetics | Adult | Female | Neoplasms, Second Primary - genetics | Liver Neoplasms - secondary | Real-Time Polymerase Chain Reaction | Gene Expression Regulation, Neoplastic - genetics | Neoplasms, Second Primary - blood supply | Neoplasms, Multiple Primary - genetics | Colorectal Neoplasms - blood supply | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Membrane Proteins - genetics | Ribonuclease, Pancreatic - genetics | Liver Neoplasms - surgery | Neoplasms, Multiple Primary - secondary | Neoplasms, Multiple Primary - pathology | Disease Progression | Neoplasms, Second Primary - secondary | Liver - blood supply | Liver Neoplasms - blood supply | Neovascularization, Pathologic - genetics | Aged | Neoplasms, Multiple Primary - blood supply | Colorectal Neoplasms - pathology | Neoplasms, Second Primary - pathology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis
by Fasol, U and Frost, A and Büchert, M and Arends, J and Fiedler, U and Scharr, D and Scheuenpflug, J and Mross, K
Annals of Oncology, ISSN 0923-7534, 04/2012, Volume 23, Issue 4, pp. 1030 - 1036
Background: EndoTAG-1 (ET), a novel formulation of cationic liposomes carrying embedded paclitaxel (Taxol), shows antitumoral activity, targeting tumor... 
EndoTAG-1 | Angiogenesis | Contrast-enhanced ultrasound (CEUS) | Pharmacokinetic profile | DCE-MRI | Liver metastasis | liver metastasis | ADVANCED SOLID TUMORS | CATIONIC LIPOSOMES | MRI | angiogenesis | CHEMOTHERAPY | pharmacokinetic profile | MELANOMA | ONCOLOGY | COLORECTAL-CANCER | GROWTH | contrast-enhanced ultrasound (CEUS) | TYROSINE KINASE INHIBITOR | PHASE-I | Paclitaxel - pharmacology | Area Under Curve | Humans | Middle Aged | Angiotensin II - blood | Magnetic Resonance Imaging - methods | Male | Paclitaxel - pharmacokinetics | Pancreatic Neoplasms - drug therapy | Colorectal Neoplasms - drug therapy | Ultrasonography | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Liver Neoplasms - secondary | Pancreatic Neoplasms - blood | Colorectal Neoplasms - blood supply | Interleukins - blood | Pancreatic Neoplasms - pathology | Liver Neoplasms - drug therapy | Vascular Endothelial Growth Factor A - blood | Angiogenesis Inhibitors - pharmacology | Angiogenesis Inhibitors - pharmacokinetics | Breast Neoplasms - drug therapy | Liver Neoplasms - diagnostic imaging | Paclitaxel - therapeutic use | Endothelin-1 - blood | Contrast Media | Liver Neoplasms - blood supply | Breast Neoplasms - pathology | Breast Neoplasms - blood | Aged | Liposomes | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Tumor angiogenic marker expression levels during tumor growth: Longitudinal assessment with molecularly targeted microbubbles and US imaging
by Deshpande, Nirupama and Ren, Ying and Foygel, Kira and Rosenberg, Jarrett and Willmann, Jürgen K
Radiology, ISSN 0033-8419, 03/2011, Volume 258, Issue 3, pp. 804 - 811
Purpose: To evaluate the use of molecularly targeted microbubbles (MBs) and ultrasonography (US) in the noninvasive assessment of the level of expression of... 
ULTRASOUND | ENDOGLIN | INTEGRIN | MICE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CONTRAST AGENT | CANCER-THERAPY | Pancreatic Neoplasms - metabolism | Humans | Pancreatic Neoplasms - blood supply | Intracellular Signaling Peptides and Proteins - metabolism | Mammary Neoplasms, Experimental - metabolism | Integrins - metabolism | Neovascularization, Pathologic - diagnostic imaging | Ovarian Neoplasms - diagnostic imaging | Endoglin | Flow Cytometry | Statistics, Nonparametric | Ultrasonography | Biomarkers, Tumor - metabolism | Microbubbles | Female | Mammary Neoplasms, Experimental - blood supply | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - blood supply | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Mammary Neoplasms, Experimental - diagnostic imaging | Animals | Image Processing, Computer-Assisted | Contrast Media - metabolism | Mice | Pancreatic Neoplasms - diagnostic imaging | Index Medicus | Abridged Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights